- Lane HC, Masur H, Gelmann EP, et al. Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. Am J Med 1985;78:417-422
- Phillips AN, Lundgren JD. The CD4 lymphocyte count and risk of clinical progression. Curr Opin HIV AIDS 2006;1:43-49
- Lundgren JD, Babiker A, El-Sadr W, et al. Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ cell counts and HIV RNA levels during follow-up. J Infect Dis 2008;197:1145-1155
- Wong, S.Y., et al., Physiologically stable vanadium(IV) porphyrins as a new class of anti -HIV agents. Chem Commun (Camb), 2005(28): p. 3544-6.
- Ross, A., et al., Oxovanadium(IV) cyclam and bicyclam complexes: potential CXCR4 receptor antagonists. Inorg Chem. 49(3): p. 1122-32.
- Chuanshu Huang, Min Ding et. al. Vanadium-induced Nuclear Factor of Activated T Cells Activation through Hydrogen Peroxide. The Journal of Biological Chemistry 276, 22397-22403.
- Wai-Yin Sun, R., et al., Some uses of transition metal complexes as anti-cancer and anti- HlV agents. Dalton Transactions, 2007(43): p. 4884-4892.
- D’Cruz, 0.1, B. Waurzyniak, and F.M. Uckun, Antiretroviral spermicide W[-II-07 prevents vaginal and rectal transmission of feline immunodeficiency virus in domestic cats. Antimicrob Agents Chemother, 2004. 48(4): p. 1082-8.
- D’Cruz OJ, Dong Y et al. Potent dual anti-HIV and spermicidal activities of novel oxovanadium(V) complexes with thiourea non-nucleoside inhibitors of HIV-1 reverse transcriptase. Biochem Biophys Res Commun. 2003 Mar 7;302(2):253-64.
- Aiuti, F. and I. Mezzaroma, Failure to reconstitute CD4+ T-cells despite suppression of HlV replication under HAART. AIDS Rev, 2006. 8(2): p. 88-97.
- Gavin C. K. W. Koh, et al; Glyburide Is Anti-inflammatory and Associated with Reduced Mortality in Melioidosis. Clin Infect Dis 2011; 52 (6): 717-725. doi: 10.1093/cid/ciq192
- Haque S et al.,HIV Promotes NLRP3 Inflammasome Complex Activation in Murine HIV-Associated Nephropathy. Am J Pathol. 2016 Feb;186(2):347-58. doi: 10.1016/j.ajpath.2015.10.002. Epub 2015 Dec 10
- Lamkanfi M, Mueller JL, Vitari AC, et al. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. The Journal of Cell Biology. 2009;187(1):61-70. doi:10.1083/jcb.200903124.
- Stover, J., et al., Interaction of dipicolinatodioxovanadium(V) with polyatomic cations and surfaces in reverse micelles. Langmuir, 2005. 21(14): p. 6250-8.
- Hosker, J.P., et al., Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients. Diabeto!ogia, 1985. 28(11): p. 809-14.
- Matthews, D.R., et al., Control ofpulsatile insulin secretion in man. Diabeto!ogia, 1983.24(4): p. 231-7.
- Loomba-Albrecht, L.A., et al., An oral sulfonylurea in the treatment of transient neonatal diabetes mellitus. Clin Ther, 2009. 31(4): p. 816-20.
- Wambach, J. A., et al., Successful sulfonylurea treatment of an insulin-naive neonate with diabetes mellitus due to aKCNJ]J mutation. Pediatr Diabetes. 11(4): p. 286-8.
- Proks, P., R. Ashfield, and F.M. Ashcroft, Interaction of vanadate with the cloned beta cellK(ATP) channel. J Biol Chem, 1999. 274(36): p. 25393-7.
- Stanik, J., et al., Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJIJ and 4BCC8 mutation carriers. J Clin Endocrinol Metab, 2007. 92(4): p. 1276-82.
- Bremer, A.A., S. Ranadive, and R.H. Lustig, Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJJ] activating mutation from subcutaneous insulin to oral glyburide. Pediatr Diabetes, 2008. 9(3 Pt 1): p. 236-9.
- Stover, J., et al., Interaction of dipicolinatodioxovanadium(V) with polyatomic cations and surfaces in reverse micelles. Langmuir, 2005. 21(14): p. 6250-8.
- Hosker, J.P., et al., Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients. Diabeto!ogia, 1985. 28(11): p. 809-14.
- Matthews, D.R., et al., Control ofpulsatile insulin secretion in man. Diabeto!ogia, 1983.24(4): p. 231-7.
- Loomba-Albrecht, L.A., et al., An oral sulfonylurea in the treatment of transient neonatal diabetes mellitus. Clin Ther, 2009. 31(4): p. 816-20.
- Wambach, J. A., et al., Successful sulfonylurea treatment of an insulin-naive neonate with diabetes mellitus due to aKCNJ]J mutation. Pediatr Diabetes. 11(4): p. 286-8.
- Proks, P., R. Ashfield, and F.M. Ashcroft, Interaction of vanadate with the cloned beta cellK(ATP) channel. J Biol Chem, 1999. 274(36): p. 25393-7.
- Stanik, J., et al., Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJIJ and 4BCC8 mutation carriers. J Clin Endocrinol Metab, 2007. 92(4): p. 1276-82.
- Bremer, A.A., S. Ranadive, and R.H. Lustig, Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJJ] activating mutation from subcutaneous insulin to oral glyburide. Pediatr Diabetes, 2008. 9(3 Pt 1): p. 236-9.
- Frazer IH, Mackay IR et al.Immunological abnormalities in asymptomatic homosexual men: correlation with antibody to HTLV-III and sequential changes over two years. Q J Med. 1986 Oct; 61(234):921-33.
- Aiuti, F. and I. Mezzaroma, Failure to reconstitute CD4+ T-cells despite suppression of HlV replication under HAART. AIDS Rev, 2006. 8(2): p. 88-97.
- J Biol Chem. 1997 May 16;272(20):12968-77. Activation of HIV-1 long terminal repeat transcription and virus replication via NF-kappaB-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds.Barbeau B(1), Bernier R, Dumais N, Briand G, Olivier M, Faure R, Posner BI,
- Cortizo AM, Ruderman G, Mazzini FN, Molinuevo MS, Mogilner IG. Novel Vanadium-Loaded Ordered Collagen Scaffold Promotes Osteochondral Differentiation of Bone Marrow Progenitor Cells. International Journal of Biomaterials. 2016;2016:1486350. doi:10.1155/2016/1486350.
Articles
epiadmin
2018-03-27T03:37:33+00:00